DR6 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - ACADIA Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 18.66 EUR 0.08% Market Closed

Market Cap: €3.1B

A	ACADIA Pharmaceuticals Inc F:DR6	US
	Hanjaya Mandala Sampoerna Tbk PT F:HSZ	ID
L	Luk Fook Holdings (International) Ltd XMUN:LUY1	HK
P	PagerDuty Inc F:2TY	US

Profitability Summary

ACADIA Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

92%

Strong 3Y Average Gross Margin

97%

Declining Gross Margin

98% > 92%

Low Operating Margin

10%

Strong 3Y Average Operating Margin

33%

Operating Margin is Increasing

-32% > 10%

Exceptional Net Margin

36%

Strong 3Y Average Net Margin

47%

Net Margin is Increasing

-28% > 36%

Healthy Free Cash Flow Margin

Strong 3Y Average Free Cash Flow Margin

19%

Free Cash Flow Margin is Increasing

-28% > 1%

Exceptional ROE

40%

Positive 3Y Average ROE

Exceptional 3Y Average ROIC

88%

ROIC is Increasing

-82% > 834%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.